• Home
• Partneringtools
• Reports

• In-licensing
• Out-licensing
• Companies

• Articles
• Events
• Outsourcing

• Consulting
• Jobs
• Forums

• About us
• Products
• Newsletter

Pharmalicensing Ltd
is a division of

— OR AKIVA, Israel, May 20

OR AKIVA, Israel, May 20 /PRNewswire/ -- ITGI Medical, Ltd. (TASE: ITGI) a company engaged with research, development, manufacturing and marketing of heterologous tissue covered stents, announced today the launch of the CE certified Over and Under(R) Pericardium Covered Stent (PCS), in the UK, Switzerland and Ireland.

Over and Under(R) is a stent 100% covered with a heterologous tissue, designed to set a barrier between the coronary blood vessel wall and its lumen. It is intended for situations such as degenerated Saphenous Vein Graft (SVG), aneurysms and perforations.

"There is great unmet medical need for stents that are 100% covered, biocompatible and flexible," noted Dr. Haim Danenberg, Head of Interventional Cardiology Unit and the company's medical director. "ITGI's Over and Under(R) PCS is a breakthrough product that would provide the interventional cardiology the ability to separate the blood from the vessel wall while minimizing adverse events."

"Over and Under(R) PCS is especially suitable for patients with degenerated SVG where the lesions are less calcified than those in native coronaries," says Efri Argaman, CEO of ITGI Medical. "Over and Under(R), as the rest of our heterologous covered stents, brings a new message to the interventional medicine and the therapeutic solutions the physicians can provide their patients."

At its initial step, ITGI launches Over and Under(R) PCS in England, one of the largest target markets in Europe. In collaboration with Pyramed, ITGI's distributor in England. In parallel, the Company launches its sales in Ireland together with its local distributor Lecks Medical and in Switzerland through Euromed Endovascular.

About Over and Under(R)

Over and Under(R) is a unique stent, first in a series of heterologous tissue covered stents, designed to set a barrier between the blood vessel wall and its lumen. Over and Under(R) PCS is indicated for treatment of bypass stenosis, aneurysms and for emergency situations such as perforations.

About ITGI Medical

ITGI medical is engaged with research and development, manufacturing and marketing of heterologous tissue covered stents. Over and Under(R) is the first among series of heterologous covered stents designed to treat coronary lesions and aneurysms. The world stent market has a value estimation of 6.4 Billion USD, of which 37% are generated in the USA. Visit: http://www.itgimedical.com

Contact: Danna Moran Director of Marketing ITGI Medical Ltd. P: +972-72-2200335 dannam@itgimedical.com

Industry news: Pharmalicensing provides comprehensive industry coverage.

Products:	Partnering Consulting	Partnering Search	Company Profiling	Comparision	Partneringtools	Reports
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Outsourcing
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search	Add your event
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic	Post your article
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Company releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us